SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PE Biosystems (PEB)
PEB 11.490.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mel Spivak who started this subject7/17/2000 11:33:30 AM
From: bob zagorin  Read Replies (1) of 122
 
PE Biosystems to Conduct Business Under the Name Applied Biosystems

FOSTER CITY, Calif.--(BW HealthWire)--July 17, 2000--PE Biosystems Group (NYSE:PEB), a PE Corporation business, announced today it will now conduct business under the name Applied Biosystems Group. The company will seek formal stockholder approval of this name change at its annual meeting in October.

"The Applied Biosystems name is well known in the life science marketplace," said Michael W. Hunkapiller, Ph.D., president of Applied Biosystems and senior vice president of PE Corporation. "Using this name will consolidate our name recognition as a provider of key technologies for new discoveries, pharmaceuticals and applied markets."

To accommodate the new group name, the current Applied Biosystems division will now operate under the name Molecular Biology.

Founded in 1981, Applied Biosystems, Inc. was acquired by The Perkin-Elmer Corporation in 1993. In 1998 The Perkin-Elmer Corporation created the PE Biosystems Division consisting of Applied Biosystems, PerSeptive Biosystems, PE Informatics, and Tropix. In 1999 The Perkin-Elmer Corporation changed its name to PE Corporation in connection with the recapitalization of the company and the sale of its analytical instruments business. The PE Biosystems Division then became the PE Biosystems Group.

PE Corporation comprises two operating groups. The PE Biosystems Group (NYSE:PEB), now conducting business under the Applied Biosystems name, with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software and contract services to the life science industry and research community. PE Biosystems is headquartered in Foster City, CA. The Celera Genomics Group (NYSE:CRA), headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. Information about the company, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the worldwide web at www.pecorporation.com or by phoning 800/762-6923.

Copyright(c)2000. PE Corporation. All Rights Reserved.

Celera, Celera Genomics, PE Biosystems, and Applied Biosystems are trademarks of PE Corporation.

CONTACT:

PE Biosystems Group, Foster City

Jay Rhodes, 650/554-2581 (Media)

or

Peter Dworkin, 650/554-2479 (Investors)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext